Table 3.
Re-Analysis of EBV Using Prospective Samples to Investigate Viral Load Disparity Seen with Galileo and qPCR Assays
| Sample identification | Galileo assay, log10 IU/mL | qPCR assay, log10 IU/mL | Log difference |
|---|---|---|---|
| EBV 1 | ND | 3.70 | |
| EBV 2 | 3.54 | 3.62 | 0.08 |
| EBV 3 | 3.54 | 4.14 | 0.60 |
| EBV 4 | 4.82 | 3.46 | 1.36 |
| EBV 5 | ND | 3.38 | |
| EBV 6 | ND | 3.38 | |
| EBV 7 | 2.77 | 3.43 | 0.66 |
| EBV 8 | 3.87 | 3.96 | 0.09 |
| EBV 9 | 3.5 | 3.66 | 0.16 |
| EBV 10 | 3.72 | 4.56 | 0.84 |
| EBV 11 | 4.75 | 4.52 | 0.23 |
| EBV 12 | 3.79 | 3.41 | 0.38 |
| EBV 13 | 3.65 | 3.70 | 0.05 |
| EBV 14 | ND | 3.65 | |
| EBV 15 | 2.51 | 3.40 | 0.89 |
| EBV 16 | 2.94 | 3.56 | 0.62 |
| EBV 17 | 2.42 | 3.23 | 0.81 |
| EBV 18 | 2.75 | 3.20 | 0.45 |
| EBV 19 | 1.82 | 3.18 | 1.36 |
| EBV 20 | ND | 3.18 |
EBV, Epstein–Barr virus; ND, not determined; qPCR, real-time quantitative PCR.